Cargando…

FOXM1 contributes to treatment failure in acute myeloid leukemia

Acute myeloid leukemia (AML) patients with NPM1 mutations demonstrate a superior response to standard chemotherapy treatment. Our previous work has shown that these favorable outcomes are linked to the cytoplasmic relocalization and inactivation of FOXM1 driven by mutated NPM1. Here, we went on to c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Irum, Halasi, Marianna, Patel, Anand, Schultz, Rachael, Kalakota, Nandini, Chen, Yi-Hua, Aardsma, Nathan, Liu, Li, Crispino, John D., Mahmud, Nadim, Frankfurt, Olga, Gartel, Andrei L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129129/ https://www.ncbi.nlm.nih.gov/pubmed/30089730 http://dx.doi.org/10.1172/jci.insight.121583

Ejemplares similares

FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML
por: Chesnokov, Mikhail S, et al.
Publicado: (2021)

Suppression of FOXM1 Sensitizes Human Cancer Cells to Cell Death Induced by DNA-Damage
por: Halasi, Marianna, et al.
Publicado: (2012)

FoxM1 Is a General Target for Proteasome Inhibitors
por: Bhat, Uppoor G., et al.
Publicado: (2009)

Honokiol is a FOXM1 antagonist
por: Halasi, Marianna, et al.
Publicado: (2018)

Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
por: Bhat, Uppoor G., et al.
Publicado: (2009)

Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells
por: Chesnokov, Mikhail S., et al.
Publicado: (2021)

The oncogenic transcription factor FOXM1 and anticancer therapy
por: Gartel, Andrei L.
Publicado: (2012)

Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors
por: Gartel, Andrei L.
Publicado: (2014)

Mutual Regulation of FOXM1, NPM and ARF Proteins
por: Pandit, Bulbul, et al.
Publicado: (2015)

Thiazole Antibiotics Siomycin a and Thiostrepton Inhibit the Transcriptional Activity of FOXM1
por: Gartel, Andrei L.
Publicado: (2013)

The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA
por: Wang, Ming, et al.
Publicado: (2011)

The antagonistic duality of NPM1 mutations in AML
por: Khan, Irum, et al.
Publicado: (2022)

The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia
por: Zhang, Xiaolu, et al.
Publicado: (2012)

Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity
por: Williams, Mark S., et al.
Publicado: (2021)

Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant
por: Sandmaier, Brenda M., et al.
Publicado: (2017)

P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
por: Burkart, Madelyn, et al.
Publicado: (2023)

Favorable outcomes of NPM1(mut) AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance
por: Khan, I., et al.
Publicado: (2023)

E-business 2.0: roadmap for success
por: Kalakota, Ravi, et al.
Publicado: (2001)

Found in transcription: FOXO1 upregulates miRNAs on chromosome X
por: Gartel, Andrei L
Publicado: (2013)

Investing With Purpose
por: Aardsma, Mark
Publicado: (2016)

Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers
por: Liu, Jun, et al.
Publicado: (2021)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors
por: Mancini, M., et al.
Publicado: (2019)

FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
por: Sheng, Yue, et al.
Publicado: (2020)

Del e-commerce al e-business : el siguiente paso
por: Kalakota, Ravi
Publicado: (2001)

Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia
por: Desai, Pinkal M., et al.
Publicado: (2021)

Thiazole Antibiotic Thiostrepton Synergize with Bortezomib to Induce Apoptosis in Cancer Cells
por: Pandit, Bulbul, et al.
Publicado: (2011)

The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
por: Hou, Youxiang, et al.
Publicado: (2017)

Atypical Plasmacytic Proliferation in a Case of C3 Glomerulopathy: Pathophysiology Demystified
por: Elfituri, Osama, et al.
Publicado: (2017)

Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas
por: Maekawa, Akira, et al.
Publicado: (2016)

Gene variant profiles and tumor metabolic activity as measured by FOXM1 expression and glucose uptake in lung adenocarcinoma
por: Goodman, Ashley, et al.
Publicado: (2020)

The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors
por: De Moraes, Gabriela Nestal, et al.
Publicado: (2019)

Eryptotic Phenotype in Chronic Myeloid Leukemia: Contribution of Neutrophilic Cathepsin G
por: Govekar, Rukmini, et al.
Publicado: (2012)

Analysis of Medical Error Contributing to Missed Acute Myeloid Leukemia Diagnosis
por: Angel, Chelsea, et al.
Publicado: (2019)

Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia
por: Petti, Allegra A., et al.
Publicado: (2022)

The Contribution of Multiplexing Single Cell RNA Sequencing in Acute Myeloid Leukemia
por: Madaci, Lamia, et al.
Publicado: (2023)

FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness
por: Yuan, Bowen, et al.
Publicado: (2018)

Cerebral aspergillosis and acute myeloid leukemia
por: Matis, Georgios K, et al.
Publicado: (2013)

Services blueprint: a roadmap for execution
por: Kalakota, Ravi, et al.
Publicado: (2004)

The Aurora Kinases in Cell Cycle and Leukemia
por: Goldenson, Benjamin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a0jb9p6j009qdmnn4v597k4ctl